Profilo
Jeffrey Roger Warren served as the Chief Executive Officer of Bristol & West Plc.
He also worked as a Non-Executive Director at Oxford BioTherapeutics Ltd.
Additionally, he was a Senior Independent Non-Executive Director at Albion Venture Capital Trust PLC from 2012 to 2020.
Precedenti posizioni note di Jeffrey Roger Warren
| Società | Posizione | Fine |
|---|---|---|
| ALBION VENTURE CAPITAL TRUST PLC | Direttore/Membro del Consiglio | 05/01/2020 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Direttore/Membro del Consiglio | 14/04/2011 |
| BRISTOL &BRISTOL&W | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Bristol & West Plc
 Bristol & West Plc Regional BanksFinance Bristol & West Plc engages in the provision of lending and financial services. It also provides savings products via various distribution channels. The company was founded on April 21, 1987 and is headquartered in Bristol, the United Kingdom. | Finance |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Albion Venture Capital Trust PLC
 Albion Venture Capital Trust PLC Investment ManagersFinance Albion Venture Capital Trust PLC a evergreen fund invests in public and private companies located in the UK. The fund targets companies operating in the fields of health technology and services, consumer services and media services. It provides financing for early and later stage transactions. It makes follow on investments. | Finance |
- Borsa valori
- Insiders
- Jeffrey Roger Warren
